These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31513356)

  • 1. Immediate and short-term effects of transcatheter device closure of large atrial septal defect in senior people.
    Wang S; Pan J; Xiao B; Tang Y; Lan J; Zheng X; Yang C; Xu D; Zhang J
    Congenit Heart Dis; 2019 Nov; 14(6):939-944. PubMed ID: 31513356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of transcatheter atrial septal defect closure in the older population: a prospective study.
    Khan AA; Tan JL; Li W; Dimopoulos K; Spence MS; Chow P; Mullen MJ
    JACC Cardiovasc Interv; 2010 Mar; 3(3):276-81. PubMed ID: 20298984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder.
    Bartakian S; El-Said HG; Printz B; Moore JW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):974-80. PubMed ID: 24050864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
    Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
    J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-term effects of transcatheter secundum atrial septal defect closure on cardiac remodeling in children and adults.
    Kaya MG; Baykan A; Dogan A; Inanc T; Gunebakmaz O; Dogdu O; Uzum K; Eryol NK; Narin N
    Pediatr Cardiol; 2010 May; 31(4):474-82. PubMed ID: 20084376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial clinical experience with the GORE
    de Hemptinne Q; Horlick EM; Osten MD; Millán X; Tadros VX; Pighi M; Gonzalez Barlatey F; Alnasser SM; Miró J; Asgar AW; Ibrahim R
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):495-503. PubMed ID: 28128523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of large atrial septal defects using 40 mm amplatzer septal occluder: Single group experience with short and intermediate term follow-up.
    Dalvi B; Sheth K; Jain S; Pinto R
    Catheter Cardiovasc Interv; 2017 May; 89(6):1035-1043. PubMed ID: 27862916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenestrated Transcatheter ASD Closure in Adults with Diastolic Dysfunction and/or Pulmonary Hypertension: Case Series and Review of the Literature.
    Abdelkarim A; Levi DS; Tran B; Ghobrial J; Aboulhosn J
    Congenit Heart Dis; 2016 Dec; 11(6):663-671. PubMed ID: 27125263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Tricuspid Regurgitation After Transcatheter Closure of Atrial Septal Defect in Adult Patients: Long-Term Follow-Up.
    Takaya Y; Akagi T; Kijima Y; Nakagawa K; Ito H
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2211-2218. PubMed ID: 29055761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of F-ASO and Targeted Medical Therapy in Patients With Secundum ASD and Severe PAH.
    Yan C; Pan X; Wan L; Li H; Li S; Song H; Liu Q; Zhang F; Liu Y; Jiang Y; Wang L; Fang W
    JACC Cardiovasc Interv; 2020 Sep; 13(17):2024-2034. PubMed ID: 32800498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes After Percutaneous Closure of Ostium Secundum Atrial Septal Defect in the Young: A Nationwide Cohort Study.
    Jalal Z; Hascoët S; Gronier C; Godart F; Mauri L; Dauphin C; Lefort B; Lachaud M; Piot D; Dinet ML; Levy Y; Fraisse A; Ovaert C; Pillois X; Lusson JR; Petit J; Baruteau AE; Thambo JB
    JACC Cardiovasc Interv; 2018 Apr; 11(8):795-804. PubMed ID: 29673513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel delivery technique for atrial septal defect closure in young children utilizing the GORE
    Anderson JH; Fraint H; Moore P; Cabalka AK; Taggart NW
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1232-1238. PubMed ID: 27896910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term evaluation of electromechanical delay in patients with atrial septal defect after transcatheter closure.
    Öz A; Aruğaslan E; Çınar T; Keskin M; Hayıroğlu MI; Avşar Ş; Karataş MB; Aydın BA; Demir K; Güngör B; Bolca O
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):33-39. PubMed ID: 30062536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique.
    Kammache I; Mancini J; Ovaert C; Habib G; Fraisse A
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):665-74. PubMed ID: 21812090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First experiences with the GORE(®) Septal Occluder in children and adults with atrial septal defects.
    Nyboe C; Hjortdal VE; Nielsen-Kudsk JE
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):929-34. PubMed ID: 23404677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of duct occluder in transcatheter closure of secundum atrial septal defect with no rim to right pulmonary vein.
    Yan C; Li S; Song H; Jin J; Zheng H; Wang C; Zhao S
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1603-1608. PubMed ID: 30712912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.
    Grohmann J; Höhn R; Fleck T; Schmoor C; Stiller B
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):E51-7. PubMed ID: 24664494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect.
    Sommer RJ; Love BA; Paolillo JA; Gray RG; Goldstein BH; Morgan GJ; Gillespie MJ;
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1285-1295. PubMed ID: 31943749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: Results of the multicenter U.S. IDE trial.
    Gillespie MJ; Javois AJ; Moore P; Forbes T; Paolillo JA;
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1296-1304. PubMed ID: 32108423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of atrial septal defect in a geriatric population.
    Nakagawa K; Akagi T; Taniguchi M; Kijima Y; Goto K; Kusano KF; Itoh H; Sano S
    Catheter Cardiovasc Interv; 2012 Jul; 80(1):84-90. PubMed ID: 22234992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.